Literature DB >> 18938743

Moving forward in human mammary stem cell biology and breast cancer prognostication using ALDH1.

Danuta Balicki1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18938743     DOI: 10.1016/j.stem.2007.10.015

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


× No keyword cloud information.
  42 in total

Review 1.  Cancer stem cells as a potential therapeutic target in breast cancer.

Authors:  Mingzhi Zhang; Zhaoming Li; Xudong Zhang; Yu Chang
Journal:  Stem Cell Investig       Date:  2014-07-16

Review 2.  Can nanomedicines kill cancer stem cells?

Authors:  Yi Zhao; Daria Y Alakhova; Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2013-10-10       Impact factor: 15.470

3.  Aldehyde dehydrogenase-1 is a specific marker for stem cells in human lung adenocarcinoma.

Authors:  Dong Liang; Yuzhi Shi
Journal:  Med Oncol       Date:  2011-04-12       Impact factor: 3.064

Review 4.  Are breast cancer stem cells the key to resolving clinical issues in breast cancer therapy?

Authors:  Hidetaka Shima; Akimitsu Yamada; Takashi Ishikawa; Itaru Endo
Journal:  Gland Surg       Date:  2017-02

5.  Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer.

Authors:  Yun Su; Qi Qiu; Xingqiao Zhang; Zhengran Jiang; Qixin Leng; Zhenqiu Liu; Sanford A Stass; Feng Jiang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02       Impact factor: 4.254

6.  Expression and prognostic value of the aldehyde dehydrogenase 1 (ALDH1) and N-myc downstream regulated gene 2 (NDRG2) as potential markers in human astrocytomas.

Authors:  Peyman Karimi Goudarzi; Farzad Mehrabi; Reza Jalili Khoshnood; Ali Baradaran Bagheri; Koorosh Ahmadi; Emad Yahaghi; Hesam Abdolhoseinpour
Journal:  Tumour Biol       Date:  2015-11-30

7.  Reversing paclitaxel resistance in ovarian cancer cells via inhibition of the ABCB1 expressing side population.

Authors:  Rachel Eyre; Ian Harvey; Katherine Stemke-Hale; Thomas W J Lennard; Alison Tyson-Capper; Annette P Meeson
Journal:  Tumour Biol       Date:  2014-07-04

8.  Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.

Authors:  Feng Jiang; Qi Qiu; Abha Khanna; Nevins W Todd; Janaki Deepak; Lingxiao Xing; Huijun Wang; Zhenqiu Liu; Yun Su; Sanford A Stass; Ruth L Katz
Journal:  Mol Cancer Res       Date:  2009-03-10       Impact factor: 5.852

9.  ALDH enzymatic activity and CD133 positivity and response to chemotherapy in ovarian cancer patients.

Authors:  Francesca Ricci; Sergio Bernasconi; Luca Porcu; Eugenio Erba; Nicolò Panini; Robert Fruscio; Federica Sina; Valter Torri; Massimo Broggini; Giovanna Damia
Journal:  Am J Cancer Res       Date:  2013-04-03       Impact factor: 6.166

10.  Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro.

Authors:  Wojciech Filipiak; Andreas Sponring; Tomas Mikoviny; Clemens Ager; Jochen Schubert; Wolfram Miekisch; Anton Amann; Jakob Troppmair
Journal:  Cancer Cell Int       Date:  2008-11-24       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.